Santa Cruz Biotechnology offers a broad range of NKG2-C monoclonal antibodies for immunology and cell biology research. NKG2-C monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NKG2-C is a member of the NKG2 family of receptors, which play a critical role in the immune response by recognizing stressed or infected cells. The receptor is primarily expressed on natural killer (NK) cells and certain T cells, contributing to the regulation of immune surveillance and the elimination of tumor cells. Understanding the function of NKG2-C is essential for developing therapeutic strategies against cancer and infectious diseases. NKG2-C research has revealed significant insights into immune system regulation and cellular defense mechanisms. Ongoing studies continue to uncover new aspects of NKG2-C's role in immune responses and disease progression. Researchers can explore complex immune pathways and cellular interactions through detailed analysis of NKG2-C expression and function. Santa Cruz Biotechnology monoclonal antibodies for NKG2-C support the scientific community in advancing our understanding of immune system regulation and potential therapeutic applications.